These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36776964)

  • 1. Single-cell RNA sequencing identifies
    Hanai A; Kawabata A; Nakajima K; Masuda K; Urakawa I; Abe M; Yamazaki Y; Fukumoto S
    Front Physiol; 2023; 14():1102751. PubMed ID: 36776964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active vitamin D and vitamin D analogs stimulate fibroblast growth factor 23 production in osteocyte-like cells via the vitamin D receptor.
    Yashiro M; Ohya M; Mima T; Nakashima Y; Kawakami K; Yamamoto S; Kobayashi S; Yano T; Tanaka Y; Sonou T; Tatsuta K; Negi S; Shigematsu T
    J Pharm Biomed Anal; 2020 Apr; 182():113139. PubMed ID: 32045827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteocytes and the pathogenesis of hypophosphatemic rickets.
    Yamazaki M; Michigami T
    Front Endocrinol (Lausanne); 2022; 13():1005189. PubMed ID: 36246908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro regulation of fibroblast growth factor 23 by 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D synthesized by osteocyte-like MC3T3-E1 cells.
    Ratsma DMA; Muller M; Koedam M; Zillikens MC; van der Eerden BCJ
    Eur J Endocrinol; 2023 Oct; 189(4):448-459. PubMed ID: 37796032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.
    Ichikawa S; Austin AM; Gray AK; Econs MJ
    J Bone Miner Res; 2012 Feb; 27(2):453-60. PubMed ID: 22006791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated gene expression in the primary osteoblasts and osteocytes isolated from hypophosphatemic Hyp mice.
    Miyagawa K; Yamazaki M; Kawai M; Nishino J; Koshimizu T; Ohata Y; Tachikawa K; Mikuni-Takagaki Y; Kogo M; Ozono K; Michigami T
    PLoS One; 2014; 9(4):e93840. PubMed ID: 24710520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic role of Fgf23 in Dmp1-null mice.
    Liu S; Zhou J; Tang W; Menard R; Feng JQ; Quarles LD
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E254-61. PubMed ID: 18559986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D3 (1,25D) on osteocyte like cells.
    Ito N; Findlay DM; Anderson PH; Bonewald LF; Atkins GJ
    J Steroid Biochem Mol Biol; 2013 Jul; 136():183-6. PubMed ID: 23064198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired 1,25 dihydroxyvitamin D3 action and hypophosphatemia underlie the altered lacuno-canalicular remodeling observed in the Hyp mouse model of XLH.
    Yuan Y; Jagga S; Martins JS; Rana R; Pajevic PD; Liu ES
    PLoS One; 2021; 16(5):e0252348. PubMed ID: 34043707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of osteocytes in phosphate metabolism.
    Michigami T
    Front Endocrinol (Lausanne); 2022; 13():967774. PubMed ID: 35909535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
    Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.
    Murali SK; Andrukhova O; Clinkenbeard EL; White KE; Erben RG
    PLoS Biol; 2016 Apr; 14(4):e1002427. PubMed ID: 27035636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteocyte-specific deletion of Fgfr1 suppresses FGF23.
    Xiao Z; Huang J; Cao L; Liang Y; Han X; Quarles LD
    PLoS One; 2014; 9(8):e104154. PubMed ID: 25089825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of osteocytes from human trabecular bone.
    Prideaux M; Schutz C; Wijenayaka AR; Findlay DM; Campbell DG; Solomon LB; Atkins GJ
    Bone; 2016 Jul; 88():64-72. PubMed ID: 27109824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHEX, FGF23, DMP1 and beyond.
    Strom TM; Jüppner H
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):357-62. PubMed ID: 18660670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha,25-dihydroxyvitamin D3 acts predominately in mature osteoblasts under conditions of high extracellular phosphate to increase fibroblast growth factor 23 production in vitro.
    Yamamoto R; Minamizaki T; Yoshiko Y; Yoshioka H; Tanne K; Aubin JE; Maeda N
    J Endocrinol; 2010 Sep; 206(3):279-86. PubMed ID: 20530653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth-related skeletal changes and alterations in phosphate metabolism.
    Michigami T; Tachikawa K; Yamazaki M; Nakanishi T; Kawai M; Ozono K
    Bone; 2022 Aug; 161():116430. PubMed ID: 35577326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
    Liu S; Gupta A; Quarles LD
    Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets.
    Wöhrle S; Henninger C; Bonny O; Thuery A; Beluch N; Hynes NE; Guagnano V; Sellers WR; Hofmann F; Kneissel M; Graus Porta D
    J Bone Miner Res; 2013 Apr; 28(4):899-911. PubMed ID: 23129509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic role of Fgf23 in Hyp mice.
    Liu S; Zhou J; Tang W; Jiang X; Rowe DW; Quarles LD
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E38-49. PubMed ID: 16449303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.